RSSCommentary

Neuroscience is the Next Oncology

Neuroscience is the Next Oncology

| April 1, 2018 | 0 Comments

by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts.

Continue Reading

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

| June 1, 2017 | 0 Comments

by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending Psychiatrist at Natchaug Hospital, Norwich, Connecticut. Innov Clin Neurosci. 2017;14(5–6):25–27 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest relevant to the content of this article. Keywords: Opioids, diversion, safety, confidentiality, adolescents Abstract: Patients receiving […]

Continue Reading

It’s Time for Combination Therapies in Multiple Sclerosis

It’s Time for Combination Therapies in Multiple Sclerosis

| June 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South Carolina. Innov Clin Neurosci. 2017;14(5–6):28–30 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest […]

Continue Reading

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

| April 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina. Innov Clin Neurosci. 2017;14(3–4):38–40

Continue Reading

The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?

The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?

| December 1, 2016 | 0 Comments

by Rocco Salvatore Calabrò, MD, PhD; Antonino Naro, MD, PhD; Rosaria De Luca, MS, PhD; Margherita Russo, MD, PhD; Lory Caccamo, PhD; Alfredo Manuli, MS; Alessia Bramanti; and Placido Bramanti, MD Drs. Calabró, Naro, de Luca, Russo, Manuli, A. Bramanti, and P. Bramanti are from the IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy; and Dr. […]

Continue Reading